Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic/cutaneous lupus erythematosus patients

J Dermatol. 2018 Aug;45(8):1020-1022. doi: 10.1111/1346-8138.14512.

Authors

Chikako Kishi¹, Sei-Ichiro Motegi¹, Masahito Yasuda¹, Osamu Ishikawa¹

Affiliation

¹ Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan.

PMID: 30133802
DOI: 10.1111/1346-8138.14512

No abstract available

MeSH terms

Adolescent
Adult
Aged
Antirheumatic Agents / pharmacology
Antirheumatic Agents / therapeutic use*
Diarrhea / chemically induced
Diarrhea / epidemiology
Drug Eruptions / epidemiology
Drug Eruptions / etiology
Female
Humans
Hydroxychloroquine / adverse effects
Hydroxychloroquine / therapeutic use*
Lupus Erythematosus, Cutaneous / drug therapy*
Lupus Erythematosus, Cutaneous / immunology
Lupus Erythematosus, Systemic / drug therapy*
Lupus Erythematosus, Systemic / immunology
Male
Middle Aged
Nausea / chemically induced
Nausea / epidemiology
Retrospective Studies
Treatment Outcome
Young Adult

Substances

Antirheumatic Agents
Hydroxychloroquine